In Vitro Evaluation of the Combinatorial Effect of Naringenin and Miltefosine against <i>Leishmania amazonensis</i>
<i>Leishmania amazonensis</i> causes a clinical form called diffuse cutaneous leishmaniasis (DCL) with challenges to treatment, like low efficiency and drug toxicity. Therefore, it is necessary to investigate new therapies using less toxic leishmanicidal compounds, such as flavonoids like naringenin...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
MDPI AG
2024-08-01
|
| Col·lecció: | Pharmaceuticals |
| Matèries: | |
| Accés en línia: | https://www.mdpi.com/1424-8247/17/8/1014 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|